Cbfa1 and topoisomerase I mRNA LEVELS decline during cellular aging of human trabecular osteoblasts

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 55, Issue 4, 2000, Pages

  Christiansen, Mette ^b   Kveiborg, Marie ^b   Kassem, Moustapha ^b   Clark, Brian F C ^b   Rattan, Suresh I S ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ARTICLE; CELL AGING; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG FIBROBLAST; OSSIFICATION; OSTEOBLAST; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN FIBROBLAST; TRABECULAR BONE;

EID: 0034015067     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/55.4.B194     Document Type: Article

References (44)

1. Ankersen L, Kassem M, Østergaard LH, Eriksen EF, Clark BFC, Rattan SIS. Aging of human trabecular osteoblasts in culture. Arch Gerontol Geriatr. 1994;Suppl 4:5-12.
2. Kassem M, Ankersen L, Eriksen EF, Clark BFC, Rattan SIS. Demonstration of cellular aging and senescence in serially passaged long-term cultures of human trabecular osteoblasts. Osteoporos Int. 1997;7: 514-524.
3. Campisi J. Replicative senescence: an old lives' tale? Cell. 1996;84: 497-500.
4. Kveiborg M, Kassem M, Langdahl B, Eriksen EF, Clark BFC, Rattan SIS. Telomere shortening during ageing of human osteoblasts in vitro and leukocytes in vivo: lack of excessive telomere loss in osteoporotic patients. Mech Ageing Dev. 1999;106:261-271.
5. Gonos ES, Dervenzi A, Kveiborg M, et al. Cloning and identification of genes that associate with mammalian replicative senescence. Exp Cell Res. 1998;240:66-74.
6. 3 reduces age-related impairment of human osteoblast functions in culture. Manuscript submitted for publication.
7. Parfitt AM. Bone remodelling: relationship to the amount and structure of bone, and the pathogenesis and prevention of fractures. In: Riggs BL, Melton LJ, eds. Osteoporosis: Etiology, Diagnosis and Management. New York: Raven Press: 1988:45-93.
8. Kassem M, Melton LJ III, Riggs BL. The type I/type II model for involutional osteoporosis. In: Marcus R, Feldman D, Kelsey J, eds. Osteoporosis. New York: Academic Press; 1996:691-702.
9. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997;89: 747-754.
10. Levanon D, Negreanu V, Bernstein Y, Bar-Am I, Avivi L, Groner Y. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics. 1994;23:425-432.
11. Wijmenga C, Speck NA, Dracopoli NC, Hofker MH, Liu P, Collins FS. Identification of a new murine runt domain-containing gene, Cbfa3, and localization of the human homolog, CBFA3, to chromosome 1p35-pter. Genomics. 1995;26:611-614.
12. Otto F, Thornell AP, Crompton T, et al. Cbfa1, a candidate gene for cleidodranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 1997;89:765-771.
13. Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997;89:755-764.
14. Mundlos S, Otto F, Mundlos C, et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell. 1997;89: 773-779.
15. Merriman HL, van Wijnen AJ, Hiebert S, et al. The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/ runt domain transcription factor family: interactions with the osteocalcin gene promoter. Biochemistry. 1995;34:13125-13132.
16. Geoffroy V, Ducy P, Karsenty G. A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element. J Biol Chem. 1995;270:30973-30979.
17. Banerjee C, McCabe LR, Choi JY, et al. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J Cell Biochem. 1997;66:1-8.
18. Stein GS, Lian JB, Wijnen AJ, Stein JL. The osteocalcin gene: a model for multiple parameters of skeletal-specific transcriptional control. Mol Biol Rep. 1997;24:185-196.
19. Geoffroy V, Corral DA, Zhou L, Lee B, Karsenty G. Genomic organization, expression of the human CBFA1 gene, and evidence for an alternative splicing event affecting protein function. Mamm Genome. 1998;9:54-57.
20. Xiao ZS, Thomas R, Hinson TK, Quarles LD. Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor. Gene. 1998;214:187-197.
21. Gupta M, Fujimori A, Pommier Y. Eukaryotic DNA topoisomerases I. Biochim Biophys Acta. 1995;1262:1-14.
22. Andersen AH, Svejstrup JQ, Westergaard O. The DNA binding, cleavage, and religation reactions of eukaryotic topoisomerases I and II. Adv Pharmacol. 1994;29A:83-101.
23. Stewart L, Redinbo MR, Qiu X, Hol WG, Champoux JJ. A model for the mechanism of human topoisomerase I. Science. 1998;279:1534-1541.
24. Muller MT, Pfund WP, Mehta VB, Trask DK. Eukaryotic type I topoisomerase is enriched in the nucleolus and catalytically active on ribosomal DNA. EMBO J. 1985;4:1237-1243.
25. Kim RA, Wang JC. A subthreshold level of DNA topoisomerases leads to the excision of yeast rDNA as extrachromosomal rings. Cell. 1989;57:975-985.
26. Sinclair DA, Guarente L. Extrachromosomal rDNA circles - a cause of aging in yeast. Cell 1997;91:1033-1042.
27. Hamelin C, Cousineau L, Dion M, Yelle J. Increased DNA topoisomerase I activity in aging human cell chromatin. Biosci Rep. 1984;4: 861-868.
28. Lee SW, Fukunaga N, Rigney DR, Shin DY, Wei JY. Downregulation of DNA topoisomerase I in old versus young human diploid fibroblasts. Mutat Res. 1997;373:179-184.
29. Kassem M, Blum W, Ristelli J, Mosekilde L, Eriksen EF. Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro. Calcif Tissue Int. 1993;52:222-226.
30. Rattan SIS, Clark BFC. Kinetin delays the onset of ageing characteristics in human fibroblasts. Biochem Biophys Res Commun. 1994;201: 665-672.
31. Huschtscha LI, Holliday R. Limited and unlimited growth of SV40-transformed cells from human diploid MRC-5 fibroblasts. J Cell Sci. 1983;63:77-99.
32. Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A. 1995;92:9363-9367.
33. Davis LG, Dibner MD, Battey JF. Basic Methods in Molecular Biology. New York: Elsevier Science; 1986.
34. Khan A, Chelly J, RT-PCR and mRNA quantitation. In: Mullis KB, Ferre F, Gibbs RA, eds. The Polymerase Chain Reaction. Boston: Birkhauser; 1994:97-109.
35. Kassem M, Okazaki R, Harris SA, Spelsberg TC, Conover CA, Riggs BL. Estrogen effects on insulin-like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor. Calcif Tissue Int. 1998;62:60-66.
36. Mansur NR, Meyer-Siegler K, Wurzer JC, Sirover MA. Cell cycle regulation of the glyceraldehyde-3-phosphate dehydrogenase/uracil DNA glycosylase gene in normal human cells. Nucleic Acids Res. 1993;21: 993-998.
37. Goldsworthy SM, Goldsworthy TL, Sprankle CS, Butterworth BE. Variation in expression of genes used for normalization of Northern blots after induction of cell proliferation. Cell Prolif. 1993;26:511-518.
38. Harada H, Tagashira S, Fujiwara M, et al. Cbfa1 isoforms exert functional differences in osteoblast differentiation. J Biol Chem. 1999;274: 6972-6978.
39. Ogawa E, Maruyama M, Kagoshima H, et al. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc Natl Acad Sci USA. 1993;90:6859-6863.
40. Yeh G, Olmsted EA, Manthur S, et al. Characterization of the use of alternative first exons in the human Cbfa-1 gene. Bone. 1998;23:T191.
41. Bohr V, Anson RM, Mazur S, Dianov G. Oxidative DNA damage processing and changes with aging. Toxicol Lett. 1998;102-103:47-52.
42. Michishita E, Nakabayashi K, Ogino H, Suzuki T, Fujii M, Ayusawa D. DNA topoisomerase inhibitors induce reversible senescence in normal human fibroblasts. Biochem Biophys Res Commun. 1998;253: 667-671.
43. Husain I, Mohler JL, Seigler HF, Besterman JM. Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. Cancer Res. 1994;54:539-536.
44. Giaccone G, van Ark-Otte J, Scagliotti G, et al. Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung. Biochim Biophys Acta. 1995;1264:337-346.